BETAPharmaceuticals
BETA Technologies, Inc Class A Common Stock — Quarterly Results & Earnings
₹1661.10
+0.00%
Profit Growth YoY-2.13%Latest quarter
Sales Growth YoY12.92%Latest quarter
Sales CAGR 5Y31.89%5 year compound
Profit CAGR 5Y37.14%5 year compound
📋
Quarterly Performance
YoY Profit Growth-2.13%
⚠️ Mild contraction
YoY Sales Growth+12.92%
✅ Strong growth
OPM 5Y Average
21.53%Operating profit margin
EPS Growth 5Y
37.15%Interest Coverage
6.03Higher = safer debt servicing
ROE
25.86%ROCE
27.04%💡
Growth Analysis
BETA Technologies, Inc Class A Common Stock reported YoY profit growth of -2.13% and revenue growth of 12.92% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 31.89% and profits at 37.14% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on BETA Technologies, Inc Class A Common Stock
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.